These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7528377)

  • 21. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
    Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
    Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal serum markers. Estimation of the risk of Down's syndrome: a prospective study.
    Mancini G; Perona M; Dall'Amico D; Bollati C; Albano F; Mazzone R; Rosso M; Grosso E; Migone N; Fiocchi F
    Int J Clin Lab Res; 1994; 24(1):49-53. PubMed ID: 7514056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-independent indices in second-trimester serum screening for Down's syndrome are useless.
    Zimmermann R; Reynolds TM; John R; Spencer K; Bartels I; Coombes E; Trevor S
    Prenat Diagn; 1996 Jan; 16(1):79-82. PubMed ID: 8821858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of gravidity on maternal serum markers for Down's syndrome.
    Barkai G; Goldman B; Ries L; Chaki R; Cuckle H
    Prenat Diagn; 1996 Apr; 16(4):319-22. PubMed ID: 8734805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison between age-dependent (Wald alpha program) and age-independent (Ulm index) analysis program for prenatal detection of Down's syndrome with serum markers].
    Zwahr C; Voss P; Kistner G
    Z Geburtshilfe Neonatol; 1996; 200(5):181-5. PubMed ID: 9035827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic value of the triple test in the diagnosis of Down's syndrome.
    Mol BW; Lok JJ; Voorn W; Pajkrt E; van Lith J; van der Meulen J
    Early Hum Dev; 1996 Dec; 47 Suppl():S55-8. PubMed ID: 9031842
    [No Abstract]   [Full Text] [Related]  

  • 29. [Triple screening for trisomy 21: prospective results of 7039 assessments].
    Pescia G; Dao MH; Weihs D; Gaide AC; Loertscher A; Hohlfeld P; Marguerat P; Nguyen The H; Paccaud F; Maillard C
    Rev Med Suisse Romande; 1993 Apr; 113(4):277-80. PubMed ID: 7684852
    [No Abstract]   [Full Text] [Related]  

  • 30. Antenatal screening for Down's syndrome: where are we and where next?
    Haddow JE
    Lancet; 1998 Aug; 352(9125):336-7. PubMed ID: 9717914
    [No Abstract]   [Full Text] [Related]  

  • 31. [Health Council of Netherlands recommendation 'Serum screening for risk assessment of Down syndrome for all women' poorly supported].
    Hamerlynck JV; Knuist M
    Ned Tijdschr Geneeskd; 2001 Oct; 145(42):2014-7. PubMed ID: 11695097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical experience with the triple test for Down's syndrome screening.
    Thornton JG; Cartmill RS; Williams J; Holding S; Lilford RJ
    J Perinat Med; 1991; 19(3):151-4. PubMed ID: 1721090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The triple-serum test for detection of Down syndrome and neural tube defects; the problem of a risk assessment test].
    van den Boer-van den Berg JM; Dupuis HM
    Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1286-9. PubMed ID: 7688445
    [No Abstract]   [Full Text] [Related]  

  • 34. Maternal serum screening for birth defects: results of a Connecticut regional program.
    Benn PA; Horne D; Craffey A; Collins R; Ramsdell L; Greenstein R
    Conn Med; 1996 Jun; 60(6):323-7. PubMed ID: 8706425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
    Frishman GN; Canick JA; Hogan JW; Hackett RJ; Kellner LH; Saller DN
    Obstet Gynecol; 1997 Jul; 90(1):98-101. PubMed ID: 9207822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome.
    Spencer K
    Ann Clin Biochem; 2001 Jul; 38(Pt 4):413-4. PubMed ID: 11471889
    [No Abstract]   [Full Text] [Related]  

  • 37. Multiple marker screening.
    Dickerson VM
    West J Med; 1994 Aug; 161(2):161. PubMed ID: 7524245
    [No Abstract]   [Full Text] [Related]  

  • 38. Prenatal screening for Down's syndrome.
    Gocze PM; Arany A; Freeman DA
    N Engl J Med; 1992 Dec; 327(27):1951; author reply 1952-3. PubMed ID: 1280772
    [No Abstract]   [Full Text] [Related]  

  • 39. [Maternal serum screening for Down syndrome and neural tube defects].
    van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH
    Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is maternal serum triple screening a better predictor of Down syndrome in female than in male fetuses?
    Ghidini A; Spong CY; Grier RE; Walker CN; Pezzullo JC
    Prenat Diagn; 1998 Feb; 18(2):123-6. PubMed ID: 9516012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.